[NFS-01] Neuroscience Frontier Symposium 01 Coevolution of multimodal neuroimaging and biomarkers

[NFS-01-5] Multimodal Database for Parkinson Disease in China

^○Tao Wu (Capital Medical University, China)

Tao Wu, MD PhD

Dr. Wu is a professor in the National Clinical Research Center on Geriatric Disorders, Xuanwu hospital. He is the director of Division of Parkinson's Disease Imaging Research. He obtained his MD from Tianjin Medical University in 1995 and became a neurologist. He later received post-graduate training on clinical neurophysiology at George-August University, Goettingen, Germany, and completed his clinical fellowship at Human Motor Control Section, Medical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health. He joined Xuanwu hospital in 2005.
His main research interests are using multi-modality neuroimaging methods to develop imaging biomarkers and to understand the pathophysiology of Parkinson’s disease. He has conducted a series studies on the difficulty in automatic movements in Parkinson’s disease. He was the first to apply resting state functional MRI in Parkinson’s disease. He organized Parkinson Disease Imaging Consortium of China (PDICC) in 2017, which already has 60 members. PDICC will create a resource sharing database and a big data analytics cloud platform, in order to develop imaging biomarkers for early diagnosis and progression, as well as to understand neural mechanisms of Parkinson's disease. Dr. Wu has published more than 70 SCI peer-reviewed papers.